IP Verse

Pharmaceutical Compositions Of Raltegravir, Methods Of Preparation And Use Thereof - EP2701689

The patent EP2701689 was granted to Hetero Research Foundation on Aug 23, 2017. The application was originally filed on Apr 19, 2012 under application number EP12777445A. The patent is currently recorded with a legal status of "Revoked".

EP2701689

HETERO RESEARCH FOUNDATION
Application Number
EP12777445A
Filing Date
Apr 19, 2012
Status
Revoked
Mar 13, 2020
Grant Date
Aug 23, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GILL JENNINGS & EVERYMay 23, 2018- -
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBMay 18, 2018TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS7169780
DESCRIPTIONUS7754731
DESCRIPTIONWO2006060681
DESCRIPTIONWO2006060711
DESCRIPTIONWO2010140156
INTERNATIONAL-SEARCH-REPORTUS2006177506
INTERNATIONAL-SEARCH-REPORTUS2010178339
OPPOSITIONEP1819323
OPPOSITIONEP1904067
OPPOSITIONUS2006177506
OPPOSITIONUS2010178339
OPPOSITIONUS5273758
OPPOSITIONWO2006060681
OPPOSITIONWO2006060711
OPPOSITIONWO2007087188
OPPOSITIONWO2008148798
OPPOSITIONWO2009113051
OPPOSITIONWO2012147101
SEARCHUS2009317473
SEARCHWO2006060681
SEARCHWO2006060711

Non-Patent Literature (NPL) Citations (16) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "chapter 35", Alfonso R. Gennano et al, Remington The Science and Practice of Pharmacy, (20000000), pages 658 - 659, ISBN 0683306472, XP055498182-
OPPOSITION- HONG WEN et al., Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice, (20100823), ISBN 9780470253175, page 81,82-
OPPOSITION- John Collet, Chris Moreton, "Chapter 20 - Modified-release peroral dosage forms", John Collet, Chris Moreton, M. E. AULTON, Pharmaceutics, The Science of Dosage Form Design, 2nd ed., (20020000), pages 289 - 305, XP055298170-
OPPOSITION- "Poly(ethylene glycol) and poly(ethylene oxide", Sigma Aldrich, (20080000), XP055498172-
OPPOSITION- "polyox polyethylene oxide application", Pharma Industry, (20100922), pages 1 - 29, XP055498174-
OPPOSITION- "POLYOX Water-Soluble Resins NF in Pharmaceutical Applications", Dow Brochure, (20040800), pages 1 - 12, XP055491575-
OPPOSITION- RAYMOND C ROWE et al., "Polyethylene glycol", Handbook of Pharmaceutical Excipients, (20060000), ISBN 0853696187, pages 545 - 550, XP055399278-
OPPOSITION- RAYMOND C ROWE et al., "Polyethylene oxide", Handbook of Pharmaceutical Excipients, (20060000), ISBN 0853696187, XP055491560-
OPPOSITION- RAYMOND C ROWE et al., "Polymethacrylates", Handbook of Pharmaceutical Excipients, (20060000), ISBN 0853696187, pages 553 - 557, XP055498178-
OPPOSITION- Rowe et al, Handbook of Pharmaceutical Excipients, 4th ed., (20030000), pages 460 - 461, XP055491560-
OPPOSITION- Scientific discussion, pages 1 - 51-
OPPOSITION- The Dow Chemical Company, "SENTRY™ POLYOX™ Water Soluble Resins", Technical Data Sheet, pages 1 - 5-
OPPOSITION- KIM C-J, "Drug release from compressed hydrophilic POLYOX-WSR tablets", J Pharm Sci, (19950300), vol. 84, no. 3, pages 303 - 306, XP009056336
OPPOSITION- Maggi et al, "Dissolution behaviour of hydrophilic matric tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug Dimensionality study", Biomaterials, (20020200), vol. 23, no. 4, pages 1113 - 1119, XP004323511
OPPOSITION- KORNER et al., "Influence of Different Polymer Types on the Overall Release Mechanism in Hydrophilic Matrix Tablets", Molecules, (20090000), vol. 14, pages 2699 - 2716, XP055491583
SEARCH- "Patient Information ISENTRESS", (20110201), URL: https://web.archive.org/web/20110303205528/http://www.merck.com/product/usa/pi_circulars/i/isentress/isentress_ppi.pdf, (20140916), XP055140585 [AD] 1-10 * page 3 - page 4 *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents